SPONSOR
Traws Pharma, Inc.
Total Trials
2
Recruiting
2
Phases
Phase 1, Phase 2
Traws Pharma, Inc. is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Healthy Volunteer, COVID - 19.
The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Traws Pharma, Inc.
How many clinical trials has Traws Pharma, Inc. sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Traws Pharma, Inc., of which 2 are actively recruiting participants. These trials cover conditions including Healthy Volunteer, COVID - 19. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Traws Pharma, Inc. research focus on?
Traws Pharma, Inc. clinical trials span Healthy Volunteer, COVID - 19. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Traws Pharma, Inc. clinical trial?
To participate in a Traws Pharma, Inc. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Traws Pharma, Inc. trials with current recruitment status updated daily.
Clinical Trials by Traws Pharma, Inc.
NCT07526506 Phase 1
Recruiting
Study of TRX-100 Tablets Evaluating the Safety, Pharmacokinetics, and Food Effect in Healthy Volunteers
Healthy Volunteer
NCT07157007 Phase 2
Recruiting
Early-stage Trial to Determine a Safe and Effective Dose for Ratutrelvir in Patients With Mild to Moderate COVID-19
COVID - 19
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology